Skip to main content
OpenTrials
Completed

NCT Number: NCT05690789

Awareness, Care & Treatment In Obesity Management

ACTION France is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor.

The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Novo Nordisk Investigational Site

Puteaux, 92800, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

People Living with Obesity

  • Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, aged above or equal to 18 years at the time of signing informed consent Lives in France
  • Current BMI based on self-reported height and weight of at least 30 kg/m^2

Health Care Professionals

  • Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
  • Male or female, aged greater than or equal to 18 years at the time of signing informed consent.
  • Physician with a license to practice
  • Specialty is not surgeon (including bariatric or plastic surgeon)
  • Practices in France
  • In clinical practice greater than or equal to 2 years
  • Spends at least 70 percent time in direct patient care
  • Has seen at least 100 patients in past month
  • Has seen at least 10 patients in past month needing weight management defined as: a patient with a BMI greater than or equal to 30 kg/m^2 with or without comorbidities.

Employers

  • Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
  • Age 18 years old or older
  • works in France
  • Company offers health insurance benefits
  • Responsible for making or influencing decisions about employee benefits plan or health and wellness programs
  • works in a company that has at least 20 employees
  • not affiliated with pharma, MR or advertising firms

Exclusion criteria

People Living with obesity

  • Previous participation in this study. Participation is defined as having given online consent in this study
  • Currently pregnant
  • Participates in intense fitness or body building programs
  • Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months
  • Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

Health Care Providers

  • Previous participation in this study. Participation is defined as having given informed consent in this study.
  • Unwillingness, inability, or language barriers precluding adequate understanding or cooperation.

Employers

  • Previous participation in this study. Participation is defined as having given informed consent in this study.
  • Unwillingness, inability, or language barriers precluding adequate understanding or cooperation.

Treatment and study plan

No treatment given

Other

No treatment given

Primary outcomes

  1. Weight loss motivators

    Time frame: Day 1-day of survey

    Multi-select from defined list

  2. Proportion of PLwO / participants who made serious weight loss effort

    Time frame: Day 1-day of survey

    Percentage of participants

  3. Response to weight loss discussions

    Time frame: Day 1-day of survey

    Single select from defined list

  4. Effective weight loss methods

    Time frame: Day 1-day of survey

    Multi-select from defined list

  5. Obesity attitudes

    Time frame: Day 1-day of survey

    5-point Likert scale

    1=strongly disagree to 5=strongly agree

  6. Attitudes toward prescription weight loss medication and surgery

    Time frame: Day 1-day of survey

    5-point Likert scale

    1=strongly disagree to 5=strongly agree

  7. Weight loss barriers

    Time frame: Day 1-day of survey

    Multi-select from defined list

  8. Obesity and weight management

    Time frame: Day 1-day of survey

    5-point Likert scale

    1=strongly disagree to 5=strongly agree

  9. Degree to which healthcare and society is meeting needs of people living with obesity

    Time frame: Day 1-day of survey

    5-point Likert scale

    1=strongly disagree to 5=strongly agree

Secondary outcomes

  1. Top factors for improving weight loss outcomes

    Time frame: Day 1-day of survey

    Multi-select from defined list

  2. Types of weight management goals

    Time frame: Day 1-day of survey

    Multi-select from defined list

  3. Most helpful information for participants for weight loss

    Time frame: Day 1-day of survey

    Multi-select from defined list

  4. Responsibility for improving health of people living with obesity

    Time frame: Day 1-day of survey

    Multi-select from defined list

  5. Most helpful support for weight loss

    Time frame: Day 1-day of survey

    Multi-select from defined list

  6. Effectiveness of guidelines for treating obesity

    Time frame: Day 1-day of survey

    5-point Likert scale

    1=strongly disagree to 5=strongly agree

  7. Ways participants receive information on weight loss management

    Time frame: Day 1-day of survey

    Multi-select from defined list

Sponsors and collaborators

Lead sponsor

Novo Nordisk A/S

Industry

Registry information

Official study title

Awareness, Care & Treatment In Obesity Management - An Observation in France

Acronym: ACTION-France

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jan 19, 2023
Registry last updated
Jun 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.